MEI Pharma pushes back on activist investors after failed merger

MEI Pharma is in defense mode after activist investors called for the removal of the San Diego biotech’s entire board and a cash return to shareholders.

The investors, Anson Advisors and Cable Car Capital, had tried buying the biotech earlier this year with an unsolicited bid, which MEI soundly…
Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks